ARCHIVES

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

This article is from The Cancer Letter archive.

Vol. 20 No. 19 | May 13, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

NCAB Approves CIS Recompetition, Restructuring

May 17, 1991